| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $60.1M | — | +25.9% |
| Cost of Revenue | $16.9M | — | +30.7% |
| Gross Profit | $43.2M | — | +24.0% |
| R&D Expense | $18.3M | — | +25.3% |
| SG&A Expense | $17.5M | — | -25.2% |
| Operating Income | $6.3M | — | +277.6% |
| Pre-tax Income | $5.8M | — | +294.1% |
| Income Tax | $1.0M | — | +2747.2% |
| Net Income | $4.8M | — | +258.0% |
| EPS (Basic) | $0.12 | — | +250.0% |
| EPS (Diluted) | $0.12 | — | +250.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $31.2M | -26.2% | -28.8% |
| Accounts Receivable | $96.0M | +15.8% | +50.8% |
| Current Assets | $175.6M | +7.2% | +24.9% |
| Total Assets | $430.6M | +2.8% | +10.4% |
| Current Liabilities | $75.0M | +4.3% | +16.6% |
| Long-term Debt | $66.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.7M | — | -80.6% |
| Capital Expenditures | $10.5M | — | +29.2% |
| Investing Cash Flow | -$10.5M | — | +91.5% |
| Financing Cash Flow | -$2.1M | — | -103.2% |
| Free Cash Flow | -$8.8M | — | -1744.7% |
| -3.2% |
| Total Liabilities | $150.1M | +1.6% | +6.5% |
| Stockholders' Equity | $280.5M | +3.5% | +12.6% |